BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35143059)

  • 1. Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701).
    Boss MA; Snyder BS; Kim E; Flamini D; Englander S; Sundaram KM; Gumpeni N; Palmer SL; Choi H; Froemming AT; Persigehl T; Davenport MS; Malyarenko D; Chenevert TL; Rosen MA
    J Magn Reson Imaging; 2022 Sep; 56(3):668-679. PubMed ID: 35143059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.
    Newitt DC; Zhang Z; Gibbs JE; Partridge SC; Chenevert TL; Rosen MA; Bolan PJ; Marques HS; Aliu S; Li W; Cimino L; Joe BN; Umphrey H; Ojeda-Fournier H; Dogan B; Oh K; Abe H; Drukteinis J; Esserman LJ; Hylton NM;
    J Magn Reson Imaging; 2019 Jun; 49(6):1617-1628. PubMed ID: 30350329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung Cancer: Short-Term Reproducibility of Intravoxel Incoherent Motion Parameters and Apparent Diffusion Coefficient at 3T.
    Jiang J; Yin J; Cui L; Gu X; Cai R; Gong S; Xu Y; Ma H; Mao J
    J Magn Reson Imaging; 2018 Apr; 47(4):1003-1012. PubMed ID: 28741732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraobserver and Interobserver Reproducibility of Breast Diffusion-Weighted Imaging Quantitative Parameters: Readout-Segmented vs. Single-Shot Echo-Planar Imaging.
    Hu Y; Hu Q; Zhan C; Yin T; Ai T
    J Magn Reson Imaging; 2023 Dec; 58(6):1725-1736. PubMed ID: 36807457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Alternate
    Partridge SC; Steingrimsson J; Newitt DC; Gibbs JE; Marques HS; Bolan PJ; Boss MA; Chenevert TL; Rosen MA; Hylton NM
    Tomography; 2022 Mar; 8(2):701-717. PubMed ID: 35314635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI).
    ElGendy K; Barwick TD; Auner HW; Chaidos A; Wallitt K; Sergot A; Rockall A
    Br J Radiol; 2022 Sep; 95(1138):20220418. PubMed ID: 35867890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted (DW) MRI in lung cancers: ADC test-retest repeatability.
    Weller A; Papoutsaki MV; Waterton JC; Chiti A; Stroobants S; Kuijer J; Blackledge M; Morgan V; deSouza NM
    Eur Radiol; 2017 Nov; 27(11):4552-4562. PubMed ID: 28396997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
    Giannotti E; Waugh S; Priba L; Davis Z; Crowe E; Vinnicombe S
    Eur J Radiol; 2015 Sep; 84(9):1729-36. PubMed ID: 26078100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy.
    Spick C; Bickel H; Pinker K; Bernathova M; Kapetas P; Woitek R; Clauser P; Polanec SH; Rudas M; Bartsch R; Helbich TH; Baltzer PA
    NMR Biomed; 2016 Oct; 29(10):1445-53. PubMed ID: 27553252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory study of geometric distortion correction of prostate diffusion-weighted imaging using B
    Tong A; Lemberskiy G; Huang C; Shanbhogue K; Feiweier T; Rosenkrantz AB
    J Magn Reson Imaging; 2019 Nov; 50(5):1614-1619. PubMed ID: 30990941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted quantitative MRI of pleural abnormalities: Intra- and interobserver variability in the apparent diffusion coefficient measurements.
    Priola AM; Priola SM; Gned D; Giraudo MT; Brundu M; Righi L; Veltri A
    J Magn Reson Imaging; 2017 Sep; 46(3):769-782. PubMed ID: 28117923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers.
    McDonald BA; Salzillo T; Mulder S; Ahmed S; Dresner A; Preston K; He R; Christodouleas J; Mohamed ASR; Philippens M; van Houdt P; Thorwarth D; Wang J; Shukla Dave A; Boss M; Fuller CD
    Radiother Oncol; 2023 Aug; 185():109717. PubMed ID: 37211282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurement.
    Bernardin L; Douglas NH; Collins DJ; Giles SL; O'Flynn EA; Orton M; deSouza NM
    Eur Radiol; 2014 Feb; 24(2):502-11. PubMed ID: 24275802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Diffusion-Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion-Weighting Level Matter?
    Maier SE; Wallström J; Langkilde F; Johansson J; Kuczera S; Hugosson J; Hellström M
    J Magn Reson Imaging; 2022 Mar; 55(3):842-853. PubMed ID: 34535940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravoxel Incoherent Motion Diffusion-Weighted Imaging of Lung Cancer: Comparison Between Turbo Spin-Echo and Echo-Planar Imaging.
    Wan Q; Lei Q; Wang P; Hu J; Zhang T; Yu D; Li X; Liang C
    J Comput Assist Tomogr; 2020; 44(3):334-340. PubMed ID: 32217894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeatability and Reproducibility of ADC Histogram Metrics from the ACRIN 6698 Breast Cancer Therapy Response Trial.
    Newitt DC; Amouzandeh G; Partridge SC; Marques HS; Herman BA; Ross BD; Hylton NM; Chenevert TL; Malyarenko DI
    Tomography; 2020 Jun; 6(2):177-185. PubMed ID: 32548294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate diffusion MRI with minimal echo time using eddy current nulled convex optimized diffusion encoding.
    Zhang Z; Moulin K; Aliotta E; Shakeri S; Afshari Mirak S; Hosseiny M; Raman S; Ennis DB; Wu HH
    J Magn Reson Imaging; 2020 May; 51(5):1526-1539. PubMed ID: 31625663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
    Park SY; Kim CK; Park BK; Kwon GY
    AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI study.
    Michoux NF; Ceranka JW; Vandemeulebroucke J; Peeters F; Lu P; Absil J; Triqueneaux P; Liu Y; Collette L; Willekens I; Brussaard C; Debeir O; Hahn S; Raeymaekers H; de Mey J; Metens T; Lecouvet FE
    Eur Radiol; 2021 Jul; 31(7):4514-4527. PubMed ID: 33409773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.